Stock Quote

Happy New 'Investing' Year: Complementary Reports on Daily Journal, Trina Solar, Cytokinetics, BrainStorm, and Resolute

NEW YORK, January 2, 2015 /PRNewswire/ --

Moments ago, Analysts Review released new research updates concerning several important developing situations including Daily Journal (NASDAQ: DJCO), Trina Solar (NYSE: TSL), Cytokinetics (NASDAQ: CYTK), BrainStorm (NASDAQ: BCLI), and Resolute (NYSE: REN). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.

To access our full PDF reports on a complementary basis, please visit the links below.


Today's update concerns the following companies:


Full PDF Download Links (you may have to copy and paste the following links into your browser):

DJCOResearch Report: ( ),

TSL Research Report: ( ),

CYTK Research Report: ( ),

BCLI Research Report: ( ),

REN Research Report: ( ).



Analyst Update: Financial Restatement, Record Output, Revised Ratings, Clinical Trial Update, Credit Facility Update

Reviewed by: Rohit Tuli, CFA®  

The US stock markets on Wednesday ended on a negative note amid the tumbling crude oil prices and light volume trade. In the last trading session of 2014, S&P 500 closed at 2,058.90, down 1.03%, NASDAQ Composite declined 0.87% to 4,736.05, and the Dow Jones Industrial Average edged 0.89% lower to finish the day at 17,823.07. However, the European stocks wrapped up the year on a positive note and were closed for trading on December 31, 2014. The Asian markets on the other hand ended the Wednesday's trading session on a mixed note as rising concerns over Greece's political crisis rattled the markets. Further, confirmation from HSBC that its index of China's manufacturing activity had contracted in December indicated a slowing Chinese economy despite government efforts to shore up development.

Shares of Daily Journal Corporation (Daily Journal) rallied 22% after the Company said that will restate some financial results and file an amendment to the original third quarter 10-Q submitted on August 18, 2014, after it hired a new auditor. A further detailed analysis of the proposed restatement is available in our research report.

Trina Solar Limited (Trina Solar) announced that its State Key Laboratory of PV Science and Technology has set a new world record for power output from a high efficiency multi-crystalline silicon PV module; ADR up 8.6% in trade. Read our research report on the Company to know more about the R&D breakthrough and the latest developments.

Shares of Cytokinetics Inc (Cytokinetics) continue to extend their run after brokerage firm - Roth Capital increased its price target on the biotech Company to $18 from $13. The stock has gained 63.5% since the December 22, 2014, close of $4.90. Read more about the amendment in collaboration in our research report on Cytokinetics.

Shares of Brainstorm Cell Therapeutics (BrainStorm) gained ahead of the Amytrophic Lateral Sclerosis (ALS) Treatment Phase IIa trial data release scheduled for January 5, 2015. The stock scaled almost 23% in trade to end at $4.76 on the last trading session of 2014, with a total of 3.40 million shares changing hands. What to expect from the upcoming conference call? Read our research report on Brainstorm to know more.

Shares of Resolute Energy Corp (Resolute) closed up almost 27% at $1.32, after the Company announced $150 million second lien secured term loan and amendment of senior revolving credit facility. Read the financial commentary and the details of the credit facility in our research report on Resolute.


About Analysts Review  

At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.


Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit:

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.